France's Minister for Small and Medium-Sized Enterprises plans antitrust review on meal-voucher commission rates, causing shares of issuers to drop. Response from companies and analysts' perspectives also discussed.
Cellectar Biosciences has been granted four patents for their proprietary drug delivery platform and lead drug for treating various cancers, including gliomas, lung cancer, melanoma, and more. The patents focus on targeting cancer stem cells, circulating tumor cells, and optimizing treatment effectiveness through fractionated dosing.
Bank of America's analysis reveals a shift in investor sentiment, with funds moving back into stocks and out of bonds. This article discusses the implications and raises caution about market disruptions.
Google is facing an antitrust trial with the Justice Department, shrouded in secrecy and potential consequences for its business practices.
Structure Therapeutics experiences a stock surge after positive weight-loss drug results and a $300 million private placement announcement. The company plans to advance drug development for type 2 diabetes and obesity through Phase 2b trials.
Fusion Antibodies reports a widened pretax loss for the first half of the year, with decreased revenue and concerns about future contracts. However, the company remains optimistic about a recovery in trading.
This article examines the challenges faced by electric vehicles in the political spotlight and explores possible solutions. It also highlights the environmental impact of the oil industry.
Following the end of the Hollywood writers strike, the actors union announces plans to resume negotiations with studios. Concerns arise over higher production costs and potential loss of profits.
The struggling bond market reflects economic uncertainty as a key fund faces its lowest close since the 2008 financial crisis. Rising interest rates and market selloffs are impacting bond funds, particularly those investing in longer-duration bonds.
Discover the connection between presidential elections and the economy, highlighting key factors such as employment, affordability, currency value, and growth. Understand the differing perspectives on the economy under President Biden.